PROMACTA ORAL SUSPN.
- Eltrombopag -Promacta ( 2008, Apr 2014 and Aug 2015) - @- Thrombopoietin Receptor Agonist - Hematopoietin Agents
Compositions:
Eltrombopag- mg Oral Suspension,
List of Related Indications:
Eltrombopag- mg Oral Suspension,
- Treatment of Thrombocytopenia in Patients Patients 1 year and older with Chronic Immune (Idiopathic) Thrombocytopenia(ITP) who have had an insufficient Response to Corticosteroids, Immunoglobulins, or splenectomy
Strength | Rate | Packing Style |
---|---|---|
mg | 0.00 | unit -oral suspension |